Efficacy of low dose Valganciclovir in patients with kidney transplant for cytomegalovirus prevention: a single center study
Latest Information Update: 08 May 2017
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 08 May 2017 New trial record
- 03 May 2017 Results presented at the 2017 American Transplant Congress